The interaction between aspirin and losartan on cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) substudy

被引：0
|
作者：
Fossum, E
Kjeldsen, SE
Dahlof, B
Devereux, RB
Julius, S
Snapinn, S
机构：
[1] Ullevaal Univ Hosp, Dept Cardiol, Oslo, Norway
[2] Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden
[3] Cornell Med Ctr, Div Cardiol, New York, NY USA
[4] Univ Michigan, Dept Internal Med, Div Hypertens, Ann Arbor, MI 48109 USA
[5] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2003年 / 16卷 / 05期
关键词：
losartan; aspirin; atenolol;
D O I：
10.1016/S0895-7061(03)00111-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
OR27
引用
收藏
页码：11A / 12A
页数：2
相关论文
共 50 条
  • [41] Hemoglobin levels and cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy.: A life substudy
    Smebye, M. L.
    Iversen, E. K.
    Hoieggen, A.
    Flaa, A.
    Os, I.
    Kjeldsen, S. E.
    Chattopadhyay, A.
    Lyle, P. A.
    Devereux, R. B.
    Dahlöf, B.
    JOURNAL OF HYPERTENSION, 2006, 24 : S4 - S4
  • [42] Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study
    Bang, Casper N.
    Gerdts, Eva
    Aurigemma, Gerard P.
    Boman, Kurt
    Dahlof, Bjoern
    Roman, Mary J.
    Kober, Lars
    Wachtell, Kristian
    Devereux, Richard B.
    JOURNAL OF HYPERTENSION, 2013, 31 (10) : 2060 - 2068
  • [43] Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation -: The Losartan Intervention For End point reduction in hypertension (LIFE) study
    Wachtell, K
    Hornestam, B
    Lehto, M
    Slotwiner, DJ
    Gerdts, E
    Olsen, MH
    Aurup, P
    Dahlöf, B
    Ibsen, H
    Julius, S
    Kjeldsen, SE
    Lindholm, LH
    Nieminen, MS
    Rokkedal, J
    Devereux, RB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (05) : 705 - 711
  • [44] An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: Results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands
    Boersma, Cornelis
    Carides, George W.
    Atthobari, Jarir
    Voors, Adriaan A.
    Postma, Maarten J.
    CLINICAL THERAPEUTICS, 2007, 29 (05) : 963 - 971
  • [45] Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol -: The Losartan Intervention for Endpoint reduction in hypertension study
    Kizer, JR
    Dahlöf, B
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Wachtell, K
    Edelman, JM
    Snapinn, SM
    Harris, KE
    Devereux, RB
    HYPERTENSION, 2005, 45 (01) : 46 - 52
  • [46] Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
    Devereux, Richard B.
    Dahlof, Bjorn
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (02) : 443 - 457
  • [47] Progressive hypertrophy regression with sustained pressure reduction in hypertension:: the Losartan Intervention For Endpoint Reduction study
    Devereux, RB
    Palmieri, V
    Liu, JE
    Wachtell, K
    Bella, JN
    Boman, K
    Gerdts, E
    Nieminen, MS
    Papademetriou, V
    Dahlöf, B
    JOURNAL OF HYPERTENSION, 2002, 20 (07) : 1445 - 1450
  • [48] The effect of losartan versus atenolol on hemostasis and fibrinolysis in hypertensive patients with left ventricular hypertrophy: A LIFE substudy
    Boman, KO
    Olsen, MH
    Wachtell, K
    Olofsson, M
    Ibsen, H
    Dige-Petersen, H
    Nilsson, TK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 482A - 482A
  • [49] Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients -: Losartan intervention for endpoint reduction in hypertension study
    Ibsen, H
    Olsen, MH
    Wachtell, K
    Borch-Johnsen, K
    Lindholm, LH
    Mogensen, CE
    Dahlöf, B
    Devereux, RB
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wan, Y
    HYPERTENSION, 2005, 45 (02) : 198 - 202
  • [50] Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy
    Fossum, E
    Olsen, MH
    Hoieggen, A
    Wachtell, K
    Reims, HM
    Ibsen, H
    Julius, S
    Kjeldsen, SE
    JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (06) : 375 - 380
12345